Stay updated on AK104 in NSCLC Phase II Clinical Trial
Sign up to get notified when there's something new on the AK104 in NSCLC Phase II Clinical Trial page.
Latest updates to the AK104 in NSCLC Phase II Clinical Trial page
- Check3 days agoChange DetectedAdded a site-wide funding notice and a new revision tag (v3.4.1); the previous revision (v3.4.0) is shown as a deletion.SummaryDifference0.9%
- Check10 days agoChange DetectedThe update includes UI additions such as a 'Show glossary' option and color-coded highlights for additions and deletions, along with minor footer/text changes and a revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision v3.3.4 was added to the Record History.SummaryDifference0.1%
- Check45 days agoChange DetectedRevision: v3.3.3 was added to the record history. The HHS Vulnerability Disclosure link and Revision: v3.3.2 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check74 days agoChange DetectedAn entry for revision v3.3.2 was added to the history. The previously listed revision v3.2.0 was removed.SummaryDifference0.1%
- Check81 days agoChange DetectedThe lapse in government funding notice banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%
Stay in the know with updates to AK104 in NSCLC Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 in NSCLC Phase II Clinical Trial page.